Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer

NCT00793962 is registered in ClinicalTrials.gov with Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT00793962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00793962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer
Lead sponsor
Chinese Academy of Medical Sciences
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2008
Completion date
September 30, 2018
Enrollment
810 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer